lsevier.com/) is a global business headquartered
in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part
of Reed Elsevier Group plc (
http://www.reedelsevier.com/), a world-leading
publisher and information provider. Operating in the science and medical,
legal, education and business-to-business sectors, Reed Elsevier provides
high-quality and flexible information solutions to users, with increasing
emphasis on the Internet as a means of delivery. Reed Elsevier's ticker
symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).
Media Contact
Juliette Goetzee
Head of Marketing
ScienceDirect
+31-(0)20-485-2893
j.goetzee@elsevier.com
'/>"/>SOURCE Elsevier and ScienceDirect Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
The DIG System Nonradioactive Automated
High-Throughput In Situ Hybridization:
a Powerful Tool for Functional Genomics Research2.
Quantitation of the Protein MIA as a Marker for
Chondrocytes in Research Samples3.
Control Your siRNA Research4.
Getting Started with MicroRNA Research5.
Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System6.
Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C7.
Research Organics8.
A Robust LC/MS/MS Method for the Quantitation of Very Long Chain Fatty Acids for Research into the Characterization of Peroxisomal Disorders9.
A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA)10.
Research Tools for Analysis of ZAP-7011.
Technical Specifications
Accelerating Your Research with the BD FACSCanto
High Throughput Sampler Option